Francis E Odonnell Jr's Net Worth
$2.74 Million
Who is Francis E Odonnell Jr?
Francis E Odonnell Jr has an estimated net worth of $2.74 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, BIOVEST INTERNATIONAL INC, Inhibitor Therapeutics, Inc., and ACCENTIA BIOPHARMACEUTICALS INC.
SEC CIK
Francis E Odonnell Jr's CIK is 0001066040
Past Insider Trading and Trends
2008 was Francis E Odonnell Jr's most active year for acquiring shares with 19 total transactions. Francis E Odonnell Jr's most active month to acquire stocks was the month of January. 2013 was Francis E Odonnell Jr's most active year for disposing of shares, totalling 28 transactions. Francis E Odonnell Jr's most active month to dispose stocks was the month of February. 2007 saw Francis E Odonnell Jr paying a total of $7,919,975.68 for 4,066,311 shares, this is the most they've acquired in one year. In 2014 Francis E Odonnell Jr cashed out on 756,815 shares for a total of $4,547,244.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
Chairman (Executive Officer)Francis E Odonnell Jr owns 21,315,289 units of Common Stock. From 2004 to 2020 Francis E Odonnell Jr acquired a total of 2,173,260 shares in BIODELIVERY SCIENCES INTERNATIONAL INC at a cost of $1,635,751.78, Francis also disposed a total of 3,850,623 shares of BIODELIVERY SCIENCES INTERNATIONAL INC equalling to $14,427,829.65.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.72% | 22.5K |
—
|
—
| 628.04K |
May 11
| |||
Form 4
| -1.82% | -11.25K |
$4.53 | -$50,962.50 | 605.54K |
Scheduled
|
May 6
| ||
Form 4
| -2.53% | -16.00K |
$4.45 | -$71,200.00 | 616.79K |
Scheduled
|
May 4
| ||
Form 4
| -3.06% | -20.00K |
$4.22 | -$84,400.00 | 632.79K |
Scheduled
|
Apr 20
| ||
Form 4
| +5.36% | 104.03K |
$3.61 | -$250,215.00 | 2.05M |
Scheduled
|
Mar 16 - Mar 17
| ||
Form 4
| -1.44% | -8.00K |
$5.31 | -$42,480.00 | 548.75K |
Scheduled
|
Feb 3
| ||
Form 4
| -1.42% | -8.00K |
$6.10 | -$48,800.00 | 556.75K |
Scheduled
|
Jan 2
| ||
Form 4/A
|
—
|
0
|
$4.48 | -$50,400.00 | 564.75K |
Dec 26
| |||
Form 4
| -1.77% | -10.00K |
$7.00 | -$70,000.00 | 554.75K |
Scheduled
|
Dec 26
| ||
Form 4
| -1.40% | -8.00K |
$6.86 | -$54,880.00 | 564.75K |
Scheduled
|
Dec 2
| ||
Form 4
| -1.38% | -8.00K |
$5.83 | -$46,640.00 | 572.75K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$4.74 | -$82,225.00 | 580.75K |
Scheduled
|
Oct 28
| ||
Form 4
|
—
|
0
|
$3.63 | -$89,050.00 | 580.75K |
Scheduled
|
Oct 15
| ||
Form 4
| -1.36% | -8.00K |
$4.34 | -$34,720.00 | 580.75K |
Scheduled
|
Oct 1
| ||
Form 4
| -1.34% | -8.00K |
$4.29 | -$34,320.00 | 588.75K |
Scheduled
|
Sep 3
| ||
Form 4
| -1.32% | -8.00K |
$3.82 | -$30,560.00 | 596.75K |
Scheduled
|
Aug 1
| ||
Form 4
| -1.31% | -8.00K |
$4.68 | -$37,440.00 | 604.75K |
Scheduled
|
Jul 1
| ||
Form 4
| -1.29% | -8.00K |
$4.32 | -$34,560.00 | 612.75K |
Scheduled
|
Jun 3
| ||
Form 4
| +3.76% | 22.5K |
—
|
—
| 620.75K |
May 9
| |||
Form 4
| -1.32% | -8.00K |
$4.77 | -$38,160.00 | 598.25K |
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4
| -1.30% | -8.00K |
$5.19 | -$41,520.00 | 606.25K |
Scheduled
|
Apr 1
| ||
Form 4
| +17.86% | 93.07K |
$5.21 | -$373,504.90 | 614.25K |
Scheduled
|
Mar 20 - Mar 21
| ||
Form 4
| +4.62% | 23K |
$5.07 | -$116,610.00 | 521.19K |
Scheduled
|
Mar 1
| ||
Form 4
| -1.58% | -8.00K |
$4.60 | -$36,800.00 | 498.19K |
Scheduled
|
Feb 1
| ||
Form 4
| -1.56% | -8.00K |
$3.64 | -$29,120.00 | 506.19K |
Scheduled
|
Jan 2
| ||
Form 4
| -1.53% | -8.00K |
$3.72 | -$29,760.00 | 514.19K |
Scheduled
|
Dec 3
| ||
Form 4
| -1.51% | -8.00K |
$3.84 | -$30,720.00 | 522.19K |
Scheduled
|
Nov 1
| ||
Form 4
| -1.49% | -8.00K |
$2.75 | -$22,000.00 | 530.19K |
Scheduled
|
Oct 1
| ||
Form 4
| +39.01% | 151.04K |
$2.84 | -$428,284.09 | 538.19K |
Scheduled
|
Sep 12 - Sep 13
| ||
Form 4
| -2.02% | -8.00K |
$2.79 | -$22,320.00 | 387.15K |
Scheduled
|
Aug 17
| ||
Form 4
| +2.59% | 9.97K |
$2.55 | -$9,952.50 | 395.15K |
Jun 25
| |||
Form 4
| +41.97% | 113.88K |
$2.14 | -$243,222.54 | 385.17K |
Scheduled
|
Mar 7 - Mar 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +0.66% | 1.77K |
$1.90 | -$1,425.00 | 271.3K |
Scheduled
|
Mar 22 - Mar 23
| ||
Form 4
| +92.97% | 129.86K |
$1.91 | -$247,551.40 | 269.53K |
Scheduled
|
Feb 15 - Feb 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| -7.22% | -100.00K |
$2.57 | -$256,500.00 | 1.29M |
Sep 22 - Sep 23
| |||
Form 4
| -17.80% | -300.00K |
—
|
—
| 1.39M |
Jun 15
| |||
Form 4
| +12.03% | 15K |
$2.05 | $30,750.00 | 139.67K |
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
| -10.61% | -200.00K |
—
|
—
| 1.69M |
Dec 23
| |||
Form 4
| -13.82% | -20.00K |
$6.00 | -$120,000.00 | 124.67K |
Nov 24
| |||
Form 4
| -2.58% | -50.00K |
$6.01 | -$300,500.00 | 1.89M |
Nov 24
| |||
Form 4
| -12.15% | -20.00K |
$6.43 | -$128,600.00 | 144.67K |
Scheduled
|
Sep 3
| ||
Form 4
| +8.89% | 13.44K |
$4.65 | -$2.52 | 164.67K |
Aug 21
| |||
Form 4
| -3.25% | -65.00K |
$8.03 |
—
| 1.94M |
Jun 16
| |||
Form 4
| -10.37% | -17.49K |
$8.03 | -$173,328.09 | 151.23K |
Scheduled
|
Jun 15 - Jun 16
| ||
Form 4
| +60.23% | 63.42K |
$14.44 | -$794,150.00 | 168.72K |
Scheduled
|
Feb 20 - Feb 23
| ||
Form 4
| -11.36% | -270.00K |
$11.99 | -$239,200.00 | 2.11M |
Dec 26
| |||
Form 4
| +1.20% | 28.18K |
$7.03 | $5.60 | 2.38M |
Jun 25
| |||
Form 4
| -5.06% | -125.00K |
$11.04 | -$1,380,000.00 | 2.35M |
Jun 11
| |||
Form 4
| -1.98% | -50.00K |
$8.04 | -$402,000.00 | 2.47M |
Mar 26
| |||
Form 4
|
—
|
0
|
$8.91 | -$1,400.00 | 2.52M |
Scheduled
|
Feb 20
| ||
Form 4
| -3.81% | -100.00K |
$6.01 | -$601,000.00 | 2.52M |
Jan 16
| |||
Form 4
| -3.67% | -100.00K |
$6.20 | -$620,000.00 | 2.62M |
Jan 10
| |||
Form 4
| -5.22% | -150.00K |
$5.90 | -$885,000.00 | 2.72M |
Dec 23
| |||
Form 4
| -3.37% | -100.00K |
$5.30 | -$530,000.00 | 2.87M |
Dec 4
| |||
Form 4
| -3.26% | -100.00K |
$4.44 | -$444,000.00 | 2.97M |
Nov 15
| |||
Form 4
| -1.51% | -95.00K |
$5.36 | -$509,250.00 | 6.19M |
Sep 19
| |||
Form 4
| +0.14% | 4.53K |
$4.12 | -$0.40 | 3.17M |
Aug 14
| |||
Form 4
| -1.13% | -72.69K |
$4.40 | -$317,152.28 | 6.37M |
Jun 19 - Jun 20
| |||
Form 4
| +0.05% | 1.73K |
$4.30 | $7,426.10 | 3.23M |
Jun 5
| |||
Form 4
| -3.15% | -100.00K |
—
|
—
| 3.08M |
Apr 17
| |||
Form 4
| -3.05% | -100.00K |
—
|
—
| 3.18M |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
| -5.48% | -190.00K |
$5.46 | -$1,037,800.00 | 3.28M |
Jul 22 - Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| -6.25% | -231.03K |
—
|
—
| 3.47M |
Dec 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
| -0.42% | -15.46K |
$5.00 | -$77,295.00 | 3.7M |
Scheduled
|
Sep 5
| ||
Form 4
| -100.00% | -45.77K |
$5.09 | -$232,954.03 |
0
|
May 30
| |||
Form 4
| +12.09% | 400.4K |
$2.68 |
—
| 3.71M |
Jan 10
| |||
Form 4
| -2.80% | -100.00K |
$1.94 | -$212,550.00 | 3.47M |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
| +1.08% | 35K |
$1.70 | $59,500.00 | 3.29M |
Mar 6 - Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOVEST INTERNATIONAL INC No price found
FORMER DIRECTOR/EXEC. CHAIRMANFrancis E Odonnell Jr owns 2,991 units of Common Stock. From 2003 to 2013 Francis E Odonnell Jr acquired a total of 715,462 shares in BIOVEST INTERNATIONAL INC at a cost of $189,090.88, Francis also disposed a total of 715,462 shares of BIOVEST INTERNATIONAL INC equalling to $189,089.52.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -217.86K |
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
| +74.91% | 93.31K |
$0.35 | $1.36 | 217.86K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
|
∞
| 124.55K |
—
|
—
| 124.55K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24 - Feb 22
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 10 - Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inhibitor Therapeutics, Inc. (INTI) Snapshot price: $0.04865
See RemarksFrancis E Odonnell Jr owns 17,372,203 units of Common Stock, $.0001 par value per share which is worth $845,157.68. From 2013 to 2022 Francis E Odonnell Jr acquired a total of 29,792,203 shares in Inhibitor Therapeutics, Inc. at a cost of $481,500.00, Francis also disposed a total of 8,560,000 shares of Inhibitor Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
| +18.29% | 2.56M |
—
|
—
| 16.56M |
Jun 15
| |||
Form 4
| -18.29% | -2.56M |
—
|
—
| 11.44M |
Jun 15
| |||
Form 4
| -30.00% | -6.00M |
—
|
—
| 14M |
Jun 6
| |||
Form 4
|
∞
| 20M |
—
|
—
| 20M |
Sep 10
| |||
Form 4
| +890.44% | 7.23M |
$0.08 | $481,500.00 | 8.04M |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACCENTIA BIOPHARMACEUTICALS INC No price found
EXECUTIVE CHAIRMANFrancis E Odonnell Jr owns 21,702,365 units of Common Stock. Francis E Odonnell Jr used to own units in Series E Convertible Preferred Stock but no longer holds any shares there. From 2005 to 2013 Francis E Odonnell Jr acquired a total of 4,872,349 shares in ACCENTIA BIOPHARMACEUTICALS INC at a cost of $10,569,692.08, Francis also disposed a total of 4,642,101 shares of ACCENTIA BIOPHARMACEUTICALS INC equalling to $150,750.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -41.22% | -1.38M |
$0.01 | -$13,750.00 | 1.96M |
Nov 8
| |||
Form 4
| -13.03% | -500.00K |
—
|
—
| 3.34M |
Oct 24
| |||
Form 4
| -2.54% | -100.00K |
$0.37 | -$37,000.00 | 3.84M |
Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
| -11.27% | -500.00K |
—
|
—
| 3.94M |
Feb 17
| |||
Form 4
| -10.96% | -500.00K |
$0.20 | -$100,000.00 | 4.06M |
Dec 23
| |||
Form 4
| -57.14% | -500.00K |
—
|
—
| 375K |
Oct 5
| |||
Form 4
| +236.37% | 975.95K |
$0.99 | $223,694.46 | 1.39M |
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24 - Feb 12
| |||
Form 4
| +0.58% | 25K |
$0.95 | $23,671.12 | 4.36M |
Aug 11 - Aug 12
| |||
Form 4
| +0.58% | 25K |
$0.94 | $23,412.50 | 4.34M |
Aug 8
| |||
Form 4
| +0.58% | 25K |
$0.84 | $21,000.00 | 4.31M |
Aug 6
| |||
Form 4
| +0.59% | 25K |
$0.79 | $19,750.00 | 4.29M |
Aug 5
| |||
Form 4
| +0.59% | 25K |
$0.79 | $19,750.00 | 4.26M |
Aug 4
| |||
Form 4
| +1.19% | 50K |
$0.85 | $42,500.00 | 4.24M |
Jul 31 - Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
|
∞
| 875K |
$8.87 | $7,761,250.00 | 875K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +0.10% | 4.33K |
$8.00 | $34,664.00 | 4.39M |
Apr 3
| |||
Form 4
|
∞
| 412.89K |
—
|
—
| 412.89K |
May 15
| |||
Form 4
| +39.20% | 1.26M |
$8.00 | $2,400,000.00 | 4.48M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||